Clinical Trial Update: Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, toxicity and maximum tolerated dose of a single IV infusion of donor cytotoxic T lymphocytes specific for CMV and adenovirus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Cytomegalovirus Infection

Drugs mentioned

• Donor CMV- and Adenovirus-specific cytotoxic T lymphocytes (CMV- and Adenovirus-specific cytotoxic T cells)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Cytomegalovirus Infection, Adenovirus Infection | Phase 1 | Status: COMPLETED